A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).

Choy, H; Devore, R F; Hande, K R; Porter, L L; Rosenblatt, P; Yunus, F; Schlabach, L; Smith, C; Shyr, Y; Johnson, D H

Choy, H; Devore, R F; Hande, K R; Porter, L L; Rosenblatt, P; Yunus, F; Schlabach, L; Smith, C; Shyr, Y; Johnson, D H.

Affiliation

Choy H; Center for Radiation Oncology, Vanderbilt University Medical School, Nashville, TN 37232, USA.

Int J Radiat Oncol Biol Phys ; 47(4): 931-7, 2000 Jul 01.

Article in En | MEDLINE | ID: mdl-10863062

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Radiation-Sensitizing Agents / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2000 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links